Literature DB >> 21716298

Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.

F Sharif1, S O Hynes, K J A McCullagh, S Ganley, U Greiser, P McHugh, J Crowley, F Barry, T O'Brien.   

Abstract

Although successful, drug-eluting stents require significant periods of dual anti-platelet therapy with a persistent risk of late stent thrombosis due to inhibition of re-endothelialization. Endothelial regeneration is desirable to protect against in-stent thrombosis. Gene-eluting stents may be an alternative allowing inhibition of neointima and regenerating endothelium. We have shown that adenoviral endothelial nitric oxide synthase (eNOS) delivery can result in significantly decreased neointimal formation and enhanced re-endothelialization. Here, we examined non-viral reporter and therapeutic gene delivery from a stent. We coated lipoplexes directly onto the surface of stents. These lipostents were then deployed in the injured external iliac artery of either normal or hypercholesterolemic New Zealand White rabbits and recovered after 28 days. Lipoplexes composed of lipofectin and a reporter lacZ gene or therapeutic eNOS gene were used. We demonstrated efficient gene delivery at 28 days post-deployment in the media (21.3±7.5%) and neointima (26.8±11.2%). Liposomal delivery resulted in expression in macrophages between the stent struts. This resulted in improved re-endothelialization as detected by two independent measures compared with vector and stent controls (P<0.05 for both). However, in contrast to viral delivery of eNOS, liposomal eNOS does not reduce restenosis rates. The differing cell populations targeted by lipoplexes compared with adenoviral vectors may explain their ability to enhance re-endothelialization without affecting restenosis. Liposome-mediated gene delivery can result in prolonged and localized transgene expression in the blood vessel wall in vivo. Furthermore, lipoeNOS delivery to the blood vessel wall results in accelerated re-endothelialization; however, it does not reduce neointimal formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716298     DOI: 10.1038/gt.2011.92

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  16 in total

1.  Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization.

Authors:  Guowei Fu; Zhanjiang Yu; Yongqiang Chen; Yundai Chen; Feng Tian; Xiaoda Yang
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

2.  Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.

Authors:  Scott P Forbes; Ivan S Alferiev; Michael Chorny; Richard F Adamo; Robert J Levy; Ilia Fishbein
Journal:  Atherosclerosis       Date:  2013-06-29       Impact factor: 5.162

Review 3.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus.

Authors:  Bo Jiang; Liang Du; Rowan Flynn; Nagadhara Dronadula; Jingwan Zhang; Francis Kim; David Dichek
Journal:  Hum Gene Ther       Date:  2012-09-24       Impact factor: 5.695

5.  Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction.

Authors:  Ilia Fishbein; Scott P Forbes; Michael Chorny; Jeanne M Connolly; Richard F Adamo; Ricardo A Corrales; Ivan S Alferiev; Robert J Levy
Journal:  Biomaterials       Date:  2013-06-15       Impact factor: 12.479

Review 6.  Recent advances in drug eluting stents.

Authors:  Amey S Puranik; Eileen R Dawson; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2012-10-29       Impact factor: 5.875

7.  Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration.

Authors:  Eunna Chung; Laura M Ricles; Ryan S Stowers; Seung Yun Nam; Stanislav Y Emelianov; Laura J Suggs
Journal:  Nano Today       Date:  2012-11-17       Impact factor: 20.722

8.  Gene expression profiling on the molecular action of danshen-gegen formula in a randomized placebo-controlled trial of postmenopausal women with hypercholesterolemia.

Authors:  Chi-Man Koon; Chun-Hay Ko; Xu-Xu Sun; Sandy Wan-Heng Hoi; Jacqueline Chor-Wing Tam; David Wing-Shing Cheung; King-Fai Cheng; Suet-Yee Pang; Wing-Man Lo; Ping Chook; Clara Bik-San Lau; Wai-Yee Chan; Ping-Chung Leung; Timothy Chi-Yui Kwok; Kwok-Pui Fung
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

9.  Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.

Authors:  Ilia Fishbein; Michael Chorny; Richard F Adamo; Scott P Forbes; Ricardo A Corrales; Ivan S Alferiev; Robert J Levy
Journal:  Angiol Open Access       Date:  2013

Review 10.  Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.

Authors:  Rui-Xing Yin; De-Zhai Yang; Jin-Zhen Wu
Journal:  Theranostics       Date:  2014-01-08       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.